China Biotech Services unit Pengbo Hainan sells 5.84% stake for RMB 9.3 million

• China Biotech Services shifted share-award scheme subscription from indirect unit Dynamic Healthcare to principal unit Pengbo (Hainan), moving employee platform Jiabao Zhongzhi (Hainan) to a direct stake in Pengbo (Hainan).
• Tripartite agreement dated May 13, 2026 sets a RMB 9.3 million cash subscription for 5.84% of Pengbo (Hainan) registered capital, payable within one month.
• Original plan for Jiabao Zhongzhi (Hainan) to buy 9% of Dynamic Healthcare was terminated with effect from tripartite agreement date.
• Pengbo (Hainan) registered capital was RMB 150 million before completion; audited net assets were about RMB 83.75 million as of Dec. 31, 2025.
• Group will retain control of Pengbo (Hainan); transaction treated as equity movement with no gain or loss expected in consolidated profit and loss.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Biotech Services Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260515-12161460), on May 15, 2026, and is solely responsible for the information contained therein.